2768.9000 19.50 (0.71%)
NSE Jun 27, 2025 15:31 PM
Volume: 201.7K
 

2768.90
0.71%
ICICI Securities Limited
Dr Lal PathLabs’ (Dr Lal) Q2FY25 revenue growth of 9.8% YoY was lower than our expectation, though its better EBITDA margin of 30.7% was a surprise.
Dr. Lal Pathlabs Ltd. is trading below its 30 day SMA of 2852.3
More from Dr. Lal Pathlabs Ltd.
Recommended